Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Miles D Chapman

Showing results (11-20 of 17) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 17 results.
Journal of Neuroimmunology|March 7, 2003
CSF and serum immune parameters in Sydenham's chorea: evidence of an autoimmune syndrome?Andrew J Church, Russell C Dale, Francisco Cardoso, et al.
Practical Neurology|March 18, 2022
CSF biomarkers for dementiaAshvini Keshavan, Frankie O'Shea, Miles D Chapman, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)|May 31, 2016
Do cerebrospinal fluid transfer methods affect measured amyloid β42, total tau, and phosphorylated tau in clinical practice?Ross W Paterson, Jamie Toombs, Miles D Chapman, et al.
Alzheimer'S Research & Therapy|March 22, 2018
Cerebrospinal fluid in the differential diagnosis of Alzheimer's disease: clinical utility of an extended panel of biomarkers in a specialist cognitive clinicRoss W Paterson, Catherine F Slattery, Teresa Poole, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|June 23, 2025
Clinical use and reporting of neurofilament quantification in neurological disorders: A global overviewConstance Delaby, Aurélie Ladang, Jose Martinez-Yriarte, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 24, 2025
BiomarkersConstance Delaby, Aurélie Ladang, Jose Yriarte, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 22, 2021
Clinical reporting following the quantification of cerebrospinal fluid biomarkers in Alzheimer's disease: An international overviewConstance Delaby, Charlotte E Teunissen, Kaj Blennow, et al.
Pageof 2

Showing results (11-20 of 17) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 17 results.
Journal of Neuroimmunology|March 7, 2003
CSF and serum immune parameters in Sydenham's chorea: evidence of an autoimmune syndrome?Andrew J Church, Russell C Dale, Francisco Cardoso, et al.
Practical Neurology|March 18, 2022
CSF biomarkers for dementiaAshvini Keshavan, Frankie O'Shea, Miles D Chapman, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)|May 31, 2016
Do cerebrospinal fluid transfer methods affect measured amyloid β42, total tau, and phosphorylated tau in clinical practice?Ross W Paterson, Jamie Toombs, Miles D Chapman, et al.
Alzheimer'S Research & Therapy|March 22, 2018
Cerebrospinal fluid in the differential diagnosis of Alzheimer's disease: clinical utility of an extended panel of biomarkers in a specialist cognitive clinicRoss W Paterson, Catherine F Slattery, Teresa Poole, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|June 23, 2025
Clinical use and reporting of neurofilament quantification in neurological disorders: A global overviewConstance Delaby, Aurélie Ladang, Jose Martinez-Yriarte, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 24, 2025
BiomarkersConstance Delaby, Aurélie Ladang, Jose Yriarte, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 22, 2021
Clinical reporting following the quantification of cerebrospinal fluid biomarkers in Alzheimer's disease: An international overviewConstance Delaby, Charlotte E Teunissen, Kaj Blennow, et al.
Pageof 2